Kaufmann BB, Hung DT. The fast track to multidrug resistance. Mol Cell. 2010;37(3):297-8. doi:10.1016/j.molcel.2010.01.027
Greene SE, Pinkner JS, Chorell E, et al. Pilicide ec240 disrupts virulence circuits in uropathogenic Escherichia coli. MBio. 2014;5(6):e02038. doi:10.1128/mBio.02038-14
Bhargava P, Collins JJ. Boosting bacterial metabolism to combat antibiotic resistance. Cell Metab. 2015;21(2):154-5. doi:10.1016/j.cmet.2015.01.012
Stollman N, Smith M, Giovanelli A, et al. Frozen encapsulated stool in recurrent Clostridium difficile: exploring the role of pills in the treatment hierarchy of fecal microbiota transplant nonresponders. Am J Gastroenterol. 2015;110(4):600-1. doi:10.1038/ajg.2015.81
Lobritz MA, Belenky P, Porter CBM, et al. Antibiotic efficacy is linked to bacterial cellular respiration. Proc Natl Acad Sci U S A. 2015;112(27):8173-80. doi:10.1073/pnas.1509743112
Périchon B, Goussard S, Walewski V, et al. Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp. Antimicrob Agents Chemother. 2014;58(2):936-49. doi:10.1128/AAC.01261-13
Kim HJ, Li H, Collins JJ, Ingber DE. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci U S A. 2016;113(1):E7-15. doi:10.1073/pnas.1522193112
Krueger AS, Munck C, Dantas G, et al. Simulating Serial-Target Antibacterial Drug Synergies Using Flux Balance Analysis. PLoS One. 2016;11(1):e0147651. doi:10.1371/journal.pone.0147651
Bageshwar UK, VerPlank L, Baker D, et al. High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors. PLoS One. 2016;11(2):e0149659. doi:10.1371/journal.pone.0149659
Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science. 2005;310(5748):670-4. doi:10.1126/science.1116739